BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 8708725)

  • 1. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
    Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
    J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
    Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
    Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exclusive chemotherapy in T1-T3N0 cancers of the vocal cord with complete clinical response after neoadjuvant treatment with a cisplatin-fluorouracil combination].
    Laccourreye O; Bassot V; Brasnu D; Jouffre V; Ménard M; Laccourreye H
    Presse Med; 1995 Oct; 24(29):1337-40. PubMed ID: 7494844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure.
    Laccourreye O; Veivers D; Bassot V; Ménard M; Brasnu D; Laccourreye H
    Ann Otol Rhinol Laryngol; 2002 Apr; 111(4):315-21; discussion 321-2. PubMed ID: 11991582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
    Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Limited" cancers of the glottic stage of the larynx and exclusive chemotherapy--15 years of experience].
    Laccourreye H
    Bull Acad Natl Med; 1997 Apr; 181(4):641-8; discussion 648-9. PubMed ID: 9312344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.
    Chevalier D; Laccourreye O; Brasnu D; Laccourreye H; Piquet JJ
    Ann Otol Rhinol Laryngol; 1997 May; 106(5):364-9. PubMed ID: 9153099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2N0 invading the anterior commissure.
    Laccourreye O; Muscatello L; Laccourreye L; Naudo P; Brasnu D; Weinstein G
    Am J Otolaryngol; 1997; 18(6):385-90. PubMed ID: 9395014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long term results of exclusive chemotherapy for glottic squamous cell carcinoma complete clinical responders after induction chemotherapy].
    Vachin F; Hans S; Atlan D; Brasnu D; Menard M; Laccourreye O
    Ann Otolaryngol Chir Cervicofac; 2004 Jun; 121(3):140-7. PubMed ID: 15223999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders.
    Laccourreye O; Veivers D; Hans S; Ménard M; Brasnu D; Laccourreye H
    Cancer; 2001 Sep; 92(6):1504-11. PubMed ID: 11745228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx.
    Holsinger FC; Lin HY; Bassot V; Laccourreye O
    Cancer; 2009 Sep; 115(17):3909-18. PubMed ID: 19551883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
    Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
    Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence after vertical partial laryngectomy, a conservative modality of treatment for patients with Stage I-II squamous cell carcinoma of the glottis.
    Laccourreye O; Gutierrez-Fonseca R; Garcia D; Hans S; Hacquart N; Ménard M; Brasnu D
    Cancer; 1999 Jun; 85(12):2549-56. PubMed ID: 10375101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
    Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control.
    Akimoto T; Nonaka T; Kitamoto Y; Ishikawa H; Ninomiya H; Chikamatsu K; Furuya N; Hayakawa K; Mitsuhashi N; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):995-1001. PubMed ID: 16406396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.